Skip to main content
Clinical Trials/ACTRN12623000575639
ACTRN12623000575639
Not yet recruiting
未知

aryngeal oxygen concentration and apnoea time during microlaryngeal surgery using transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) with different oxygen concentrations: A randomised controlled clinical trial

Dr Liang Voice Program, The University of Sydney0 sites102 target enrollmentMay 25, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Airway management during microlaryngeal surgery
Sponsor
Dr Liang Voice Program, The University of Sydney
Enrollment
102
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 25, 2023
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Liang Voice Program, The University of Sydney

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 years
  • \- Elective microlaryngeal surgeries, including but not limited to the following procedures:
  • Microlaryngoscopy with or without biopsy (MBS item number: 41855\)
  • Microlaryngoscopy with removal of laryngeal lesion (MBS item number: 41861\)
  • Microlaryngoscopy with removal of lesion including laser (MBS item number: 41861\)
  • Microlaryngoscopy and laryngeal injection (MBS item number: 41870\)
  • Microlaryngoscopy and treatment of subglottic stenosis
  • \- Willingness of the participant’s treating anaesthetist to enrolthe participant, in the absence of any identified contraindications.

Exclusion Criteria

  • \- Baseline oxygen saturation level less than 95%
  • \- Know history of lung disease, including but not limited to COPD and Type I or Type II respiratory failure.
  • \- Body Mass Index (BMI) greater than 31\.

Outcomes

Primary Outcomes

Not specified

Similar Trials